Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Ibrutinib

2

XII.l Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)

1
Last update : 25/12/2014
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Ibrutinib-related atrial fibrillation: Therapeutic challenges.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2019 Jul;25;1258-1260 2019 Jul
Management of adverse effects/toxicity of ibrutinib.
Critical reviews in oncology/hematology 2019 Apr;136;56-63 2019 Apr
Ibrutinib-Associated Atrial Fibrillation.
JACC. Clinical electrophysiology 2018 Dec;4;1491-1500 2018 Dec
Cardiovascular Toxic Effects of Targeted Cancer Therapies.
The New England journal of medicine 2016 Oct 13;375;1457-1467 2016 Oct 13
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
The New England journal of medicine 2014 Jul 17;371;213-23 2014 Jul 17
Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling.
Blood 2014 Dec 11;124;3829-30 2014 Dec 11

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies